Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis c virus genotype 1: are nonresponders and relapsers different populations?-Reference-Cited by-同舟云学术

Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis c virus genotype 1: are nonresponders and relapsers different populations?

Published:2007-12 Issue:6 Volume:11 Page:554-560
ISSN:1413-8670
Container-title:Brazilian Journal of Infectious Diseases
language:en
Short-container-title:Braz J Infect Dis

Author:

Silva Giovanni Faria,Polônio Rodrigo José,Pardini Maria Inês Moura Campos,Corvino Silvia Maria,Henriques Rita Maria Saccomano,Peres Mari Nilce,Silveira Liciana Vaz Arruda,Coelho Kunie Iabuki Rabello

Publisher

FapUNIFESP (SciELO)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://www.scielo.br/pdf/bjid/v11n6/06.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of the inflammatory response on treatment of hepatitis C with triple therapy;Revista da Sociedade Brasileira de Medicina Tropical;2018-12

2. Hepatitis C Worldwide and in Brazil: Silent Epidemic—Data on Disease including Incidence, Transmission, Prevention, and Treatment;The Scientific World Journal;2014

3. Sustained virological response to treatment of chronic hepatitis C with peginterferon alfa and ribavirin;Brazilian Journal of Pharmaceutical Sciences;2012-06

4. Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil;Memórias do Instituto Oswaldo Cruz;2012-03

5. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis;Bulletin of the World Health Organization;2012-02-03